Weight loss drugs have dominated the headlines over the past year, and now there’s a new medication that may be the most effective one yet.
On Nov. 8, the U.S. Food and Drug Administration (FDA) approved tirzepatide (which will be sold under the brand name Zepbound), to treat overweight and obesity. Made by Eli Lilly and Co., the drug is already approved for type 2 diabetes, as Mounjaro…
Read more